Cognitive effects of conventional and atypical antipsychotics in schizophrenia

British Journal of Psychiatry

Volumn 174, Issue MAY SUPPL. 38, 1999, Pages 44-51

  Sharma, Tonmoy ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; DOPAMINE 2 RECEPTOR BLOCKING AGENT; HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE; SERTINDOLE; ZIPRASIDONE;

AMNESIA; ATTENTION DEFICIT DISORDER; CLINICAL TRIAL; COGNITION; DRUG EFFECT; DRUG MECHANISM; EXTRAPYRAMIDAL SYMPTOM; HUMAN; NEGATIVE SYNDROME; NEUROPSYCHOLOGICAL TEST; PROBLEM SOLVING; QUALITY OF LIFE; REVIEW; SCHIZOPHRENIA; TREATMENT OUTCOME; ATTENTION; COGNITIVE DEFECT; MEMORY; PSYCHOLOGY;

ANTIPSYCHOTIC AGENTS; ATTENTION; COGNITION; COGNITION DISORDERS; HUMANS; MEMORY; NEUROPSYCHOLOGICAL TESTS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; TREATMENT OUTCOME;

EID: 0032894685     PISSN: 00071250     EISSN: None     Source Type: Journal    
DOI: 10.1192/s0007125000298103     Document Type: Review

References (87)

1. Andreasen, N. C., Rezai, K., Alliger, R., et al (1991) Hypofrontality in neuroleptic-naive patients and in patients with chronic schizophrenia. Assessment with xenon-133 single-photon emission computed tomography and the Tower of London. Archives of General Psychiatry, 49, 943-958.
2. Benton, A. L. (1974) The Revised Visual Retention Test (4th edn). New York: Psychological Corporation.
3. _ & Hamsher, K. de S. (1989) Multilingual Aphasia Examination. Iowa City, IO: University of Iowa, AJA Associates.
4. Berman, K. F., Zec., R. F. & Weinberger, D. R. (1986) Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. II. Role of neuroleptic treatment, attention and mental effort. Archives of General Psychiatry, 43, 126-135.
5. Bildar, R. M., Lipschutz Broch, L., Relter, G., et al (1992a) Intellectual deficits in first-episode schizophrenia: evidence for progressive deterioration. Schizophrenia Bulletin, 18, 437-448.
6. _ , Turkel, E., Lipschutz Broch, L., et al (1992b) Antipsychotic medication effects on neuropsychological functions. Psychopharmacology Bulletin, 28, 353-366.
7. Braff, D. L. * Geyer, M. A. (1990) Sensorimotor gating and schizophrenia. Human and animal model studies. Archives of General Psychiatry, 47, 181-188.
8. Buchanan, R. W., Holstein, C. & Breier, A. (1994) The comparative efficacy and long-term effect of clozapine treatment on neuropsychological test performance. Biological Psychiatry 36, 717-725.
9. Carter, C. S., Robertson, L. C. & Nordahl, T. E. (1991) Abnormal processing of irrelevant information In chronic schizophrenia: selective enhancement of Stroop facilitation. Psychiatry Research, 41, 37-46.
10. _ , _ , _ , et al (1993) Abnormal processing of irrelevant information in schizophrenia: the role of illness subtype. Psychiatry Research, 48, 17-26.
11. Cassens, G., Inglls, A. K., Applebaum, P. S., et al (1990) Neuroleptics: effects on neuropsychological function in chronic schizophrenic patients. Schizophrenia Bulletin, 16, 477-499.
12. Classen, W. & Laux, G. (1988) Sensorimotor and cognitive performance of schizophrenic inpatients treated with haloperidol, flupenthixol or clozapine. Pharmacopsychiatry, 21, 295-297.
13. Cleghorn, J. M., Kaplan, R. D., Szechman, B., et al (1990) Neuroleptic drug effects on cognitive function in schizophrenia. Schizophrenia Research, 3, 211-219.
14. Cohen, J. D. & Servan Schreiber-D. (1992) Context, cortex, and dopamine; a connectionist approach to behavior and biology in schizophrenia. Psychological Review, 99, 45-77.
15. Damaslo, A. & Anderson, S.W. (1991) The frontal lobes. In Clinical Neuropsychology (eds K. M. Helman and E. Valenstein), pp. 409-460. New York: Oxford University Press.
16. Daniel, D. G. (1994) Comparison of risperidone and clozapine on clinical cognitive functions in psychotic disorders (abstract). Biological Psychiatry, 35, 667.
17. Davidson, M. & Keefe, R. S. (1995) Cognitive impairment as a target for pharmacological treatment in schizophrenia. Schizophrenia Research, 17, 123-129.
18. Delahunty, A., Morice, R. & Frost, B. (1993) Specific cognitive flexibility rehabilitation in schizophrenia. Psychological Medicine, 23, 221-227.
19. Dimascio, A., Havens, L. L. & Klerman, G. L. (1963) The psychopharmacology of phenothiazine compounds: a comparative study of the effects of chlorpromazine, promethiazine, trifluoperazine and perphenazine in normal males. Introduction, aims and methods. Journal of Nervous and Mental Disease, 136, 15-78.
20. Farde, L. & Nordstrom, A.-L. (1992) PET analysis indicates atypical central dopamine receptor occupancy in clozapine-treated patients. British Journal of Psychiatry, 160 (suppl. 17), 30-33.
21. Fujii, D. E. M., Ahmed, I., Jokumsen, M., et al (1997) The effects of clozapine on cognitive functioning in treatment-resistant schizophrenic patients. Journal of Neuropsychiatry and Clinical Neurosciences, 9, 240-245.
22. Gallhofer, B., Bauer, U., Gruppe, H., et al (1996a) First episode schizophrenia: the importance of compliance and preserving cognitive function. Journal of Practical Psychiatry and Behavioral Health, 2, 165-245.
23. _ , _ , Lis, S., et al (1996b) Cognitive dysfunction in schizophrenia: comparison of treatment with atypical antipsychotic agents and conventional neuroleptic drugs. European Neuropsychopharmacology, 6 (suppl. 2), S13-S20.
24. Gold, J. M., Randolph, C., Carpenter, C. J., et al (1992) Forms of memory failure in schizophrenia. Journal of Abnormal Psychology, 101, 487-494.
25. _ & Harvey, P. D. (1993) Cognitive deficits in schizophrenia. Psychiatric Clinics of North America, 16, 295-312.
26. Goldberg, T. E., Weinberger, D. R., Berman, K. F., et al (1987) Further evidence for dementia of the prefrontal type in schizophrenia? A controlled study of teaching the Wisconsin Card Sorting Test. Archives of General Psychiatry, 44, 1008-1014.
27. _ , Ragland, J. D., Torrey, E. F., et al (1990) Neuropsychological assessment of monozygotic twins discordant for schizophrenia. Archives of General Psychiatry, 47, 1066-1072.
28. _ , Greenberg, R. D., Griffin, S. J., et al (1993a) The effect of clozapine on cognition and psychiatric symptoms In patients with schizophrenia. British Journal of Psychiatry, 162, 43-48.
29. _ , Torrey, E. F., Gold, J. M., et al (1993b) Learning and memory in monozygotic twins discordant for schizophrenia. Psychological Medicine, 23, 71-85.
30. Green, M. F. (1996) What are the functional consequences of neurocognitive deficits in schizophrenia? American journal of Psychiatry, 153, 321-330.
31. _ , Marshall, B. D., Wirshing, M. D., et al (1997) Does risperidone improve verbal working memory in treatment-resistant schizophrenia? American Journal of Psychiatry, 154, 799-804.
32. Hagger, C., Buckley, P., Kenny, J. T., et al (1993) Improvement in cognitive functions and psychiatric symptoms in treatment-refractory schizophrenic patients receiving clozapine. Biological Psychiatry, 34, 702-712.
33. Hartley, L. R. (1983) Arousal, temporal and spatial uncertainty and drug effects. Progress in Neurospychopharmacology and biological Psychiatry, 7, 29-37.
34. Harvey, P. D., Lombardi, J., Kincaid, M. M., et al (1995) Cognitive functioning in chronically hospitalized schizophrenic patients; age-related changes and age disorientation as a predictor of impairment. Schizophrenia Research, 17, 15-24.
35. Heaton, R. (1981) Wisconsin Card Sorting Manual. Odessa, FL: Psychological Assessment Resources.
36. _ , Paulsen, J. S., McAdams, L. A., et al (1994) Neuropsychological deficits in schizophrenics. Relationship to age, chronicity, and dementia. Archives of General Psychiatry, 51, 469-476.
37. Hoff, A. L., Riordan, H., O'Donnell, D. W., et al (1991) Neuropsychological functioning of first-episode schizophreniform patients. American Journal of Psychiatry, 149, 898-903.
38. _ , Faustman, W. O., Wieneke, M., et al (1996) The effects of clozapine on symptom reduction, neurocognitive function, and clinical management in treatment-refractory state hospital schizophrenic inpatients. Neuropsychopharmacology 15, 361-369.
39. Jaeger, J. & Douglas, E. (1992) Neuropsychiatric rehabilitation for persistent mental illness. Psychiatry Quarterly, 63, 71-94.
40. Kane, J., Honigfeld, G., Singer, J., et al (1988) Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazinc. Archives, of General Psychiatry, 45, 789-796.
41. Keefe, R. S., Roltman, S. E., Harvey, P. D., et al (1995) A pen-and-paper human analogue of a monkey prefrontal cortex activation task: spatial working memory in patients with schizophrenia. Schizophrenia Research, 17, 25-33.
42. Kenny, J. T. & Meltzer, H. Y. (1991) Attention and higher cortical functions in schizophrenia. Journal of Neuropsychiatry and Clinical Neuroscience, 3, 269-275.
43. King, D. J. (1990) The effect of neuroleptics on cognitive and psychomotor function. British Journal of Psychiatry, 157, 799-811.
44. _ (1994) Psychomotor impairment and cognitive disturbances induced by neuroleptics. Acta Psychiatrica Scandinavica, 380 (suppl. 38), 53-58.
45. Kornetsky, C., Pettit, M., Wynne, R., et al (1959) A comparison of the psychological effects of acute and chronic administration of chlorpromazine and secobarbital (quinalbarbitone) in schizophrenic patients. Journal of Mental Science, 105, 190-198.
46. Kraepelin, E. (1919) Dementio Proecox and Paraphrenia. Edinburgh: Livingstone.
47. Kremen, W. C., Tsuang, M. T., Faraone, S. V., et al (1992) Using vulnerability indicators to compare conceptual models of genetic heterogeneity in schizophrenia. Journal of Nervous and Mental Disease, 180, 141-152.
48. Lee, M. A., Thompson, P. A. & Meltzer, H. Y. (1994) Effects of clozapine on cognitive function in schizophrenia. Journal of Clinical Psychiatry, 55 (suppl. B), 82-87.
49. Lieberman, J. A., Saltz, B. L., Johns, C. A., et al (1991) The effects of clozapine on tardive dyskinesia. British Journal of Psychiatry, 158, 503-510.
50. Liljequist, R., Linnoila, M. & Mattila, M. J. (1978) Effects of two weeks treatment with thioridizine. chlorpromazine, sulpiride and bromazepam, alone or in combination with alcohol, on learning and memory in man. Psychopharmacologia, 55, 205-208.
51. McKenna, P. J., Tamlyn, D., Lund, C. E., et al (1990) Amnesic syndrome in schizophrenia. Psychological Medicine, 10, 967-972.
52. Marder, S. R. & Meibach, R. C. (1994) Risperidone in the treatment of schizophrenia. American Journal of Psychiatry, 151, 825-835.
53. Medallia, A., Gold, J. & Merriam, A. (1988) The effects of neuroleptics on neuropsychological test results of schizophrenics. Archives of Clinical Neuropsychology, 3, 249-271.
54. Meltzer, H. Y. (1991) The mechanism of action of novel atypical antipsychotic drugs. Schizophrenia Bulletin, 17, 263-287.
55. _ (1992) Dimensions of outcome with clozapine. British Journal of Psychiatry, 160 (suppl. 17), 46-53.
56. Minsky, A. F., Primac, D. W. & Bates, R. (1959) The effects of chlorpromazine and secoarbital on the continuous performance test. Journal of Nervous and Mental Disease, 128, 12-17.
57. Morice, R. (1990) Cognitive inflexibility and pre-frontal dysfunction in schizophrenia and mania. British Journal of Psychiatry, 157, 50-54.
58. Nelson, H. E., Pantelis, C., Carruthers, K., et al (1990) Cognitive functioning and symptomatology in chronic schizophrenia. Psychological Medicine, 20, 357-365.
59. Nuechterlein, K. H. (1983) Signal detection in vigilance tasks and behavioral attributes among offspring of schizophrenic mothers and among hyperactive children. Journal of Abnormal Psychology, 92, 4-28.
60. _ & Dawson, M. E. (1984) Information processing and attentional functioning in the developmental course of schizophrenic disorders. Schizophrenia Bulletin, 19, 160-203.
61. _ , _ & Green, M. F. (1994) Information-processing abnormalities as neuropsychological vulnerability indicators for schizophrenia. Acta Psychiatrica Scandinavica, (suppl. 384), 71-79.
62. Oltmanns, T. F. & Neale, J. M. (1975) Schizophrenic performance when distractors are present: attentional deficit or differential task difficulty? Journal of Abnormal Psychology, 84, 205-209.
63. Overall, J. E. & Gorham, D. R. (1962) The Brief Psychiatric Rating Scale. Psychiatric Reports, 10, 799-812.
64. Park, S. & Holzman, P. S. (1992) Schizophrenics show spatial working memory deficits. Archives of General Psychiatry, 49, 975-982.
65. Plisken, N., Raz, N., Raz, S., et al (1987) Neuroteptic withdrawal and deterioration of verbal fluency in schizophrenia; a preliminary report. Journal of Clinical Experimental Neuropsychology, 9, 62.
66. Rappaport, B. J., Webster, J. S. & Dutra, R. L. (1994) Digit span performance and unilateral neglect. Neuropsychologia, 32, 517-525.
67. Robins, T. W. & Brown, V. B. (1990) The role of the striatum in the mental chronometry of action: a theoretical review. Review of Neuroscience, 2, 181-204.
68. Rosvold, H. E., Mirsky, A, F., Sarason, A. F., et al (1956) A continuous performance test of brain damage. Journal of Consulting Psychology, 20, 343-350.
69. Roxborough, H, Muir, W. J., Blackwood, D. H. R., et al (1993) Neuropsychological and P300 abnormalities in schizophrenics and their relatives. Psychological Medicine, 23, 305-314.
70. Saletu, B., Grunberger, J., Linzmayer, L., et al (1987) Comparative placebo-controlled pharmacodynamic studies with zotepine and clozapine utilizing pharmaco-EFG and psychometry. Pharmacopsychiatry, 20, 12-27.
71. Saykin, A. J., Gur, R. C., Gur, R. E., et al (1991) Neuropsychological function in schizophrenia. Selective impairment in memory and learning. Archives of General Psychiatry, 48, 618-624.
72. _ , Shtasel, D. L., Gur, R. E., et al (1994) Neuropsychological deficits in neuroleptic naive patients with first-episode schizophrenia. Archives of General Psychiatry, 51, 124-131.
73. Schreiber, H., Stolz Born, G., Kornhuber, H. H., et al (1992) Event-related potential correlates of impaired selective attention in children at high risk for schizophrenia. Biological Psychiatry, 32, 634-651.
74. Sharma, T. (1995) Structural and functional endophenotypes in schizophrenia. In Neurobiology and Psychiatry (ed, R. Kerwin), vol. 3, pp. 25-32. Cambridge: Cambridge University Press.
75. _ (1996) Schizophrenia: recent advances in psychopharmacology. British Journal of Hospital Medicine, 55, 194-198.
76. _ & Mockler, D. (1998) The cognitive efficacy of atypical antipsychotics in schizophrenia. Journal of Clinical Psychopharmacology, 2 (suppl. 1), 125-195.
77. Spohn, H. E. & Strauss, M. E. (1989) Relation of neuroleptic and anticholinergic medication to cognitive functions in schirophrenia. Journal of Abnormal Psychology, 98, 367-380.
78. Sullivan, E. V., Mathalon, D. H., Ha, C. N., et al (1992) The contribution of constructional accuracy and organizational strategy to nonverbal recall in schizophrenia and chronic alcoholism. Biological Psychiatry, 32, 312-333.
79. Sweeney, J. A., Keilp, J. G., Haas, G. L., et al (1991) Relationships between medication treatments and neuropsychological test performance in schizophrenia. Psychiatry Research, 37, 297-308.
80. _ , Haas, G. L. & Li, S. (1992) Neuropsychological and eye movement abnormalities in first-episode and chronic schizophrenia. Schizophrenia Bulletin, 18, 283-293.
81. Talland, G. A. (1965) Deranged Memory. New York: Academic Press.
82. Treisman, A. & Fearnley, S. (1969) The Stroop test: selective attention to colours and words. Nature, 222, 437-439.
83. Tune, L. E., Lew, M. F., Breitlinger, E., et al (1982) Serum levels of anticholinergic drugs and impaired recent memory in chronic schizophrenic patients. American Journal of Psychiatry, 139, 1460-1462.
84. Waddington, J. L., Youssef, H. A. & Kinsella, A. (1990) Cognitive dysfunction in schizophrenia followed up over 5 years and its longitudinal relationship to the emergence of tardive dyskinesia. Psychological Medicine, 20, 835-842.
85. Walker, E. (1981) Attentional and neuro-motor functions in schizophrenia, schizoaffectives and patients with other affective disorders. Archives of General Psychiatry, 38, 1355-1358.
86. Wechsler, D. (1974) WISC-R Manual Wechsler Intelligence Scale for Children Revised New York: Psychological Corporation.
87. _ (1981) WAIS - R Manual. Wechsler Adult Intelligence Scale - Revised. New York: Psychological Corporation.